SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL

被引：6
|
作者：
Venhoff, N. [1 ]
Schmidt, W. A. [2 ]
Bergner, R. [3 ]
Rech, J. [4 ]
Unger, L. [5 ]
Tony, H. P. [6 ]
Mendelson, M. [7 ]
Sieder, C. [8 ]
Maricos, M. [8 ]
Thiel, J. [1 ,9 ]
机构：
[1] Univ Freiburg, Vasculitis Ctr Freiburg, Dept Rheumatol & Clin Immunol, Med Ctr, Freiburg, Germany
[2] Med Ctr Rheumatol Berlin Buch, Immanuel Krankenhaus Berlin, Berlin, Germany
[3] Klinikum Stadt Ludwigshafen, Med Klin, Ludwigshafen, Germany
[4] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany
[5] Stadt Klinikum Dresden, Med Dept 1, Dresden, Germany
[6] Rheumatol & Clin Immunol Oberduerrbachertstr, Dept Med 2, Wurzburg, Germany
[7] Novartis Pharmaceut, Rheumatol, Newark, NJ USA
[8] Novartis Pharma GmbH, Rheumatol, Nurnberg, Germany
[9] Med Univ Graz, Div Rheumatol & Immunol, Dept Internal Med, Graz, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.806
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0182
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial
    Balanescu, Andra Rodica
    Feist, Eugen
    Wolfram, Gernot
    Davignon, Isabelle
    Smith, Michael D.
    Brown, Mark T.
    West, Christine R.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (09) : 1665 - 1672
  • [42] The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD
    Singh, Dave
    Beier, Jutta
    Astbury, Carol
    Belvisi, Maria G.
    Da Silva, Carla A.
    Jauhiainen, Alexandra
    Jimenez, Eulalia
    Lei, Alejhandra
    Necander, Sofia
    Smith, Jaclyn A.
    Hamren, Ulrika Wahlby
    Xin, Wenjing
    Psallidas, Ioannis
    EUROPEAN RESPIRATORY JOURNAL, 2022, 59 (04)
  • [43] Zilucoplan in immune-mediated necrotising myopathy : a phase 2, randomised, double-blind, placebo-controlled, multicentre trial
    Mammen, Andrew L.
    Amato, Anthony A.
    Dimachkie, Mazen M.
    Chinoy, Hector
    Hussain, Yessar
    Lilleker, James B.
    Pinal-Fernandez, Iago
    Allenbach, Yves
    Boroojerdi, Babak
    Vanderkelen, Mark
    Delicha, Eumorphia Maria
    Koendgen, Harold
    Farzaneh-Far, Ramin
    Duda, Petra W.
    Sayegh, Camil
    Benveniste, Olivier
    LANCET RHEUMATOLOGY, 2023, 5 (02): : E67 - E76
  • [44] Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study
    Yamauchi, Toshio
    Kaneko, Sunao
    Yagi, Kazuichi
    Sase, Shinichi
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 60 (04) : 507 - 515
  • [45] Efficacy and Safety of Dichlorphenamide for the Treatment of Periodic Paralysis: a Phase 3 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
    Burge, James
    Sansone, Valeria
    McDermott, Michael
    Smith, Patty
    Herr, Barbara
    Tawil, Alrabi
    Pandya, Shree
    Kissel, John
    Ciafaloni, Emma
    Shieh, Perry
    Ralph, Jeffrey
    Amato, Anthony
    Cannon, Stephen
    Trivedi, Jaya
    Barohn, Richard
    Crum, Brian
    Mitsumoto, Hiroshi
    Pestronk, Alan
    Meola, Giovanni
    Conwit, Robin
    Jasek, Mark
    Hanna, Michael
    Griggs, Robert
    NEUROLOGY, 2016, 86
  • [46] Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial
    Ludolph, Albert C.
    Schuster, Joachim
    Dorst, Johannes
    Dupuis, Luc
    Dreyhaupt, Jens
    Weishaupt, Jochen H.
    Kassubek, Jan
    Weiland, Ulrike
    Petri, Susanne
    Meyer, Thomas
    Grosskreutz, Julian
    Schrank, Berthold
    Boentert, Matthias
    Emmer, Alexander
    Hermann, Andreas
    Zeller, Daniel
    Prudlo, Johannes
    Winkler, Andrea S.
    Grehl, Torsten
    Heneka, Michael T.
    Johannesen, Siw Wollebaek
    Goericke, Bettina
    LANCET NEUROLOGY, 2018, 17 (08): : 681 - 688
  • [47] A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Extract Sceletium tortuosum (Zembrin) in Healthy Adults
    Nell, Haylene
    Siebert, Mirna
    Chellan, Pashini
    Gericke, Nigel
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2013, 19 (11) : 898 - 904
  • [48] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Dogar, Omara
    Keding, Ada
    Gabe, Rhian
    Marshall, Anna-Marie
    Huque, Rumana
    Barua, Deepa
    Fatima, Razia
    Khan, Amina
    Zahid, Raana
    Mansoor, Sonia
    Kotz, Daniel
    Boeckmann, Melanie
    Elsey, Helen
    Kralikova, Eva
    Parrott, Steve
    Li, Jinshuo
    Readshaw, Anne
    Sheikh, Aziz
    Siddiqi, Kamran
    LANCET GLOBAL HEALTH, 2020, 8 (11): : E1408 - E1417
  • [49] The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
    Kreis, Lena
    Dejaco, Christian
    Schmidt, Wolfgang Andreas
    Nemeth, Robert
    Venhoff, Nils
    Schaefer, Valentin Sebastian
    TRIALS, 2024, 25 (01)
  • [50] Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
    Al-Chalabi, Ammar
    Shaw, Pamela
    Leigh, P. Nigel
    van den Berg, Leonard
    Hardiman, Orla
    Ludolph, Albert
    Aho, Valtteri V.
    Sarapohja, Toni
    Kuoppamaki, Mikko
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (10): : 1165 - 1170
12345